Mark Nance
Consigliere Generale presso ENVISTA HOLDINGS CORPORATION
Patrimonio netto: 576 541 $ in data 31/05/2024
Profilo
Mark E.
Nance is currently the Secretary, Senior Vice President & General Counsel at Envista Holdings Corp.
He previously worked as the General Counsel at GE Aerospace, Vice President-Corporate Development at Integrated Nano-Technologies LLC, Senior Vice President & Global General Counsel at Mylan NV, Senior Vice President & Global General Counsel at GE UK Group, and Senior Vice President & Global General Counsel at GE Healthcare Medical Diagnostics.
He also served as the Chief Legal Officer & General Counsel at INSYS Therapeutics, Inc. from 2018 to 2019.
Mr. Nance obtained his undergraduate degree from the University of Missouri and his graduate degree from Cornell Law School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ENVISTA HOLDINGS CORP.
0.02% | 25/03/2024 | 29 780 ( 0.02% ) | 576 541 $ | 31/05/2024 |
Posizioni attive di Mark Nance
Società | Posizione | Inizio |
---|---|---|
ENVISTA HOLDINGS CORPORATION | Consigliere Generale | 01/09/2019 |
Precedenti posizioni note di Mark Nance
Società | Posizione | Fine |
---|---|---|
INSYS THERAPEUTICS, INC. | Consigliere Generale | 31/07/2019 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Consigliere Generale | 01/05/2017 |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Consigliere Generale | - |
GE Healthcare Medical Diagnostics | Consigliere Generale | - |
Integrated Nano-Technologies LLC | Corporate Officer/Principal | - |
Formazione di Mark Nance
Cornell Law School | Graduate Degree |
University of Missouri | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GE AEROSPACE | Producer Manufacturing |
ENVISTA HOLDINGS CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Integrated Nano-Technologies LLC | Health Technology |
GE Healthcare Medical Diagnostics | |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
- Borsa valori
- Insiders
- Mark Nance